Related Experiment Video
Updated: May 5, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
20.3K
Emerging antiretroviral drugs
José Vicente Fernández-Montero1, Eugenia Vispo, Vicente Soriano
1Hospital Carlos III, Department of Infectious Diseases, C/Sinesio Delgado 10, Madrid, 28029 , Spain vsoriano@dragonet.es.
Expert Opinion on Pharmacotherapy
|December 3, 2013
Summary
Newer antiretroviral agents offer improved HIV treatment with higher resistance barriers and simpler administration. Advances in single-tablet regimens promise better adherence and outcomes for patients on lifelong therapy.
Area of Science:
- Pharmacology
- Infectious Diseases
- HIV Therapeutics
Background:
- Antiretroviral therapy for HIV has advanced, improving potency, tolerability, and convenience for lifelong treatment.
- Unmet needs in HIV management include reducing pill burden, improving metabolic profiles, minimizing drug interactions, and enhancing resistance barriers.
Purpose of the Study:
- To provide an updated summary of evidence-based efficacy and safety data for recently approved and upcoming antiretroviral agents.
- To review data on antiretrovirals in advanced development stages from peer-reviewed literature and international conferences.
Main Methods:
- Systematic review of published peer-reviewed literature.
- Analysis of data presented at international scientific meetings.
- Focus on antiretroviral agents in the most advanced stages of clinical development.
Main Results:
- Dolutegravir demonstrates a superior resistance barrier and simpler administration compared to other drugs in its class.
- Emerging agents like cobicistat, cenicriviroc, and tenofovir alafenamide fumarate show promising efficacy and safety profiles.
- Development of once-daily, single-tablet antiretroviral regimens is progressing.
Conclusions:
- Dolutegravir offers significant advantages in HIV treatment.
- Newer antiretroviral drugs and formulations are expanding therapeutic options.
- Advancements in single-tablet regimens are expected to improve patient adherence and treatment success.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
43.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.1K
Retroviruses
12.2K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.2K
Subviral Agents
940
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
940
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Size and Structure of Viral Genomes
1.2K
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
1.2K

